Very-Late Onset Diffuse Large B-cell Lymphoma with CD3 Coexpression in a Kidney Transplant Patient / 대한신장학회지
Korean Journal of Nephrology
;
: 689-693, 2011.
Article
in English
| WPRIM
| ID: wpr-162479
ABSTRACT
B-lineage non-Hodgkin lymphoma may aberrantly coexpress T-cell markers. In general population, however, cases of diffuse large B-cell lymphomas with CD3 co-expression are rare because the CD3 marker is the most lineage specific T-cell antigen. We report a case of CD3 coexpressed diffuse large B-cell lymphoma in a 47-year-old male patient presented with dyspepsia who had transplanted a kidney 17 years ago. An esophagogastroduodenoscopy displayed an ulcerated mass in the gastric antrum. The pathology of the mass was monomorphic post-transplant lymphoproliferative disorder - specifically, CD20- and CD3-positive diffuse large B-cell lymphoma. Resection of the mass and postop chemotherapy were performed. A follow-up computerized tomography showed disapperance of tumor. No recurrence was observed until 7 month after treatment. Nevertheless, the patient's renal function gradually aggrevated and progressed to end stage renal disease. As far as we know, this is the first case of diffuse large B-cell lymphoma with CD3 coexpression after kidney transplant.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pyloric Antrum
/
Recurrence
/
Ulcer
/
Lymphoma, Non-Hodgkin
/
B-Lymphocytes
/
T-Lymphocytes
/
Follow-Up Studies
/
Endoscopy, Digestive System
/
Lymphoma, B-Cell
/
Transplants
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
/
Male
Language:
English
Journal:
Korean Journal of Nephrology
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS